31614690|t|Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.
31614690|a|Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that govern the expression of genes responsible for energy metabolism, cellular development, and differentiation. Their crucial biological roles dictate the significance of PPAR-targeting synthetic ligands in medical research and drug discovery. Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies. In this review we aim to consolidate existing clinical evidence of PPAR modulators, highlighting their clinical prospects and challenges. Findings from clinical trials revealed that different agonists of the same PPAR subtype could present different safety profiles and clinical outcomes in a disease-dependent manner. Pemafibrate, due to its high selectivity, is likely to replace other PPARalpha agonists for dyslipidemia and cardiovascular diseases. PPARgamma agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases. The clinical niche of PPARbeta/delta agonists is less well-explored. Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis. Notably, the preclinical and clinical development for PPAR antagonists remains unacceptably deficient. We anticipate the future design of better PPAR modulators with minimal off-target effects, high selectivity, superior bioavailability, and pharmacokinetics. This will open new possibilities for PPAR ligands in medicine.
31614690	31	35	PPAR	Gene	5465
31614690	349	353	PPAR	Gene	5465
31614690	447	451	PPAR	Gene	5465
31614690	518	536	metabolic diseases	Disease	MESH:D008659
31614690	538	567	chronic inflammatory diseases	Disease	MESH:D002908
31614690	569	579	infections	Disease	MESH:D007239
31614690	581	600	autoimmune diseases	Disease	MESH:D001327
31614690	602	640	neurological and psychiatric disorders	Disease	MESH:D001523
31614690	646	658	malignancies	Disease	MESH:D009369
31614690	727	731	PPAR	Gene	5465
31614690	873	877	PPAR	Gene	5465
31614690	979	990	Pemafibrate	Chemical	MESH:C540740
31614690	1048	1057	PPARalpha	Gene	5465
31614690	1071	1083	dyslipidemia	Disease	MESH:D050171
31614690	1088	1111	cardiovascular diseases	Disease	MESH:D002318
31614690	1113	1122	PPARgamma	Gene	5468
31614690	1131	1143	pioglitazone	Chemical	MESH:D000077205
31614690	1183	1202	metabolic disorders	Disease	MESH:D008659
31614690	1208	1230	chronic kidney disease	Disease	MESH:D051436
31614690	1232	1242	depression	Disease	MESH:D003866
31614690	1244	1256	inflammation	Disease	MESH:D007249
31614690	1262	1281	autoimmune diseases	Disease	MESH:D001327
31614690	1305	1319	PPARbeta/delta	Gene	5467
31614690	1380	1384	PPAR	Gene	5465
31614690	1402	1413	chiglitazar	Chemical	MESH:C515629
31614690	1415	1427	saroglitazar	Chemical	MESH:C000588741
31614690	1429	1440	elafibranor	Chemical	MESH:C585906
31614690	1446	1458	lanifibranor	Chemical	MESH:C000619516
31614690	1539	1554	type 2 diabetes	Disease	MESH:D003924
31614690	1556	1568	dyslipidemia	Disease	MESH:D050171
31614690	1570	1603	non-alcoholic fatty liver disease	Disease	MESH:D065626
31614690	1609	1636	primary biliary cholangitis	Disease	MESH:D008105
31614690	1692	1696	PPAR	Gene	5465
31614690	1783	1787	PPAR	Gene	5465
31614690	1935	1939	PPAR	Gene	5465
31614690	Association	MESH:D009369	5465
31614690	Negative_Correlation	MESH:C515629	MESH:D003924
31614690	Association	MESH:D007249	5468
31614690	Association	MESH:D051436	5468
31614690	Negative_Correlation	MESH:C540740	MESH:D002318
31614690	Positive_Correlation	MESH:D000077205	5468
31614690	Negative_Correlation	MESH:C540740	MESH:D050171
31614690	Negative_Correlation	MESH:C000619516	MESH:D050171
31614690	Negative_Correlation	MESH:C000588741	MESH:D065626
31614690	Negative_Correlation	MESH:C000588741	MESH:D050171
31614690	Negative_Correlation	MESH:C515629	MESH:D050171
31614690	Association	MESH:D003924	5465
31614690	Positive_Correlation	MESH:C515629	5465
31614690	Negative_Correlation	MESH:C585906	MESH:D008105
31614690	Negative_Correlation	MESH:C515629	MESH:D008105
31614690	Positive_Correlation	MESH:C000619516	5465
31614690	Negative_Correlation	MESH:C000619516	MESH:D065626
31614690	Positive_Correlation	MESH:C000588741	5465
31614690	Association	MESH:D002908	5465
31614690	Negative_Correlation	MESH:C000619516	MESH:D003924
31614690	Association	MESH:D000077205	MESH:D003866
31614690	Association	MESH:D008659	5465
31614690	Negative_Correlation	MESH:C585906	MESH:D050171
31614690	Negative_Correlation	MESH:C000588741	MESH:D003924
31614690	Negative_Correlation	MESH:C000588741	MESH:D008105
31614690	Positive_Correlation	MESH:C585906	5465
31614690	Association	MESH:D002318	5465
31614690	Association	MESH:D065626	5465
31614690	Association	MESH:D008105	5465
31614690	Association	MESH:D001327	5468
31614690	Negative_Correlation	MESH:D000077205	MESH:D007249
31614690	Association	MESH:D001327	5465
31614690	Association	MESH:D001523	5465
31614690	Negative_Correlation	MESH:C000619516	MESH:D008105
31614690	Negative_Correlation	MESH:D000077205	MESH:D001327
31614690	Negative_Correlation	MESH:D000077205	MESH:D008659
31614690	Association	MESH:D050171	5465
31614690	Negative_Correlation	MESH:C585906	MESH:D065626
31614690	Association	MESH:D003866	5468
31614690	Association	MESH:D007239	5465
31614690	Negative_Correlation	MESH:D000077205	MESH:D051436
31614690	Negative_Correlation	MESH:C515629	MESH:D065626
31614690	Negative_Correlation	MESH:C585906	MESH:D003924

